Iris Dorbian

Intel Capital backs Movellus

San Jose, California and Ann Arbor, Michigan-based Movellus, which develops traditionally analog IPs, has secured an undisclosed amount of funding. The backer was Intel Capital.

4iQ grabs $18 mln Series B

Los Altos, California-based 4iQ, a provider of intelligence for identity theft protection vendors, has secured $18 million in Series B funding. C5 Capital led the round with participation from ForgePoint Capital, Adara Ventures and Benhamou Global Ventures. In addition to the funding, André Pienaar, a managing partner of C5 Capital, and Anik Bose, a general partner of BGV, will join the 4iQ's board of directors.

Spring Discovery rallies $18 mln Series A

Palo Alto, California-based Spring Discovery, a startup accelerating the discovery of therapies for aging, has raised $18 million in Series A funding, according to a post. First Round and General Catalyst led the round.

Robotiq secures funding from Battery Ventures

Quebec-based Robotiq, a provider of tools and software for the collaborative-robotics market, has raised C$31 million in funding. The investor was Battery Ventures. In conjunction with the funding, Battery General Partner Jesse Feldman will join Robotiq’s board.

Ballast Point Ventures backs Avoxi

Avoxi, a communications-as-a-service provider for global contact centers, has raised $10 million in funding. The investor was Ballast Point Ventures.

Frist Cressey Ventures collects almost $50 mln for second fund

Frist Cressey Ventures has raised almost $50 million for its second fund, according to an SEC filing. The target is $80 million. Based in Nashville, the firm invests in healthcare.

DBL Partners TIAB 2018 targets $125 mln

DBL Partners TIAB 2018 is seeking to raise $125 million, according to an SEC filing. Based in San Francisco, DBL Partners invests in companies that "enable social, environmental and economic benefits," according to its website.

Mediktor fetches $3.4 mln Series A

Brooklyn, New York-based Mediktor, a symptom checker for pre-diagnosis, triage and decision-making support, has raised $3.4 million in Series A funding. Alta Life Sciences Spain I FCR was the lead investor.

Drug developer EpiVario locks in $445K seed

Philadelphia-based EpiVario, an early-stage drug discovery and developer, has raised $445,000 in seed funding. The investors were not named.

GenEdit pulls in $8.5 mln

Berkeley, California-based GenEdit Inc, a developer of next generation therapeutics for genetic diseases, has closed $8.5 million in funding. Data Collective Bio and SK Holdings led the round with participation from other investors that included Sequoia Capital and Bow Capital.